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A B S T R A C T  
Objective: To determine frequency of raised CRP levels in children clinically diagnosed to have sepsis. 
Patients and Methods: In this cross-sectional study, a total of 91 children up to 5-year age, clinically diagnosed as 
having sepsis, were enrolled and were screened for a raised CRP level. The outcome of the study was recorded as the 
frequency of raised CRP level in children clinically suspected of having sepsis. 
Results: The results of the study showed that 95.6% (87/91) of our patients had a raised CRP level.  
Conclusion: CRP can be used as an early sensitive tool for diagnosis of bacterial sepsis. 
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I n t r o d u c t i o n  
 
C-reactive protein (CRP) is an acute-phase reactant 
whose level in the serum rises with inflammation. It is of 
hepatic origin and is a protein that increases following IL-6 
secretion by macrophages,1 in response to a wide range 
of acute and chronic inflammatory conditions such as 
bacterial, viral or fungal infections, rheumatic disorders, 
autoimmune disorders, malignancies and conditions 
causing tissue injury and necrosis.2 CRP rises within 6 
hours of the onset of inflammation and may rise up to 10, 
000 folds peaking at 48 hours. It has a half-life of about 
19 hours which is constant and hence its level is 
determined by its rate of production and therefore by the 
severity of the precipitating cause.3 It may be concluded 
that CRP is a good indicator of inflammation and may be 
used to screen for inflammation. Evaluations have been 
done to determine its diagnostic strength in this context.2  
CRP is an abnormal protein as it is not found in the serum 
of a healthy person, but increases in a matter of hours 
after onset of tissue damage or destruction, regardless of 
the cause, and disappears equally rapidly after the 
destructive process has ceased. CRP is not subject to 
normal variation, as is the erythrocyte sedimentation rate 
(ESR) and is independent of the hematocrit. In this 
respect, it is generally found to be more useful and 
sensitive marker of acute inflammatory disease than 
ESR.4  
Combined usage of total leucocyte count (TLC) and CRP 
gives a better positive predictive value in the diagnosis of 
inflammatory conditions.5 CRP is not only useful in 
determining the presence of an inflammatory disease but 
is also helpful in following its progress and effectiveness 
of treatment. In particular serial measurements of CRP is 
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very useful, for instance when one has to decide about 
the duration of antibiotic therapy in infections.6-10 The 
present study was conducted to determine the frequency 
of raised levels of qualitative CRP in children clinically 
suspected of having sepsis in our setup.   
    P a t i e n t s  a n d  M e t h o d s  
This cross-sectional study was conducted at the 
Children’s Hospital, Pakistan Institute of Medical Sciences 
(PIMS), Islamabad. The sample size was calculated as 91 
by WHO sample calculator with an anticipated population 
of 17% at 95% confidence level and absolute precision of 
0.07. A total of 91 children up to 5 years of age clinically 
suspected of having septicemia were enrolled by non-
probability consecutive sampling. Children with liver 
disease, trauma, chronic kidney disease, suspected 
rheumatic disease or other focal infections like 
pneumonia, urinary tract infections were excluded from 
the study. Clinical impression of sepsis was made if the 
patient had several of the considered signs and 
symptoms of sepsis namely fever, reluctance to feed, 
lethargy, purpura/bleeding or altered level of 
consciousness. Approval from the hospital ethical 
committee was taken. An informed written consent was 
taken from parent/caregiver after explaining the 
importance of the study. Patient profile including name, 
age sex, address, hospital number, serial number, date of 
inclusion in the study were noted. If the patient was sick, 
he /she was first stabilized before blood samples were 
taken for TLC and CRP levels.  All information was 
collected and entered into a proforma especially designed 
for this study. The data was analyzed on a computer 
using SPSS version 10.  Mean was calculated for 
numerical variables like age and total leukocyte count. 
Frequency and percentages were presented for 
categorical variables i.e. gender, positive CRP. CRP 
>5mg/dl was taken as positive. 
R e s u l t s  
In our study a total of 91 cases clinically suspected of 
having sepsis were enrolled. The mean age of the 
patients was 2.6 years ranging from 0.1 to 5 years. 
Among these, 41 (45%) of the patients were between 3 
and 5 years, 24(26.4%) were less than 1 year and 26(28. 
5%) were between 1 to 3 years. There were 54 (59%) 
males and 37 (41%) females with a male to female ratio 
of 1.4:1. As regards clinical signs and symptoms of 
sepsis, almost all patients 88(96.7%) had a fever. Other 
significant clinical findings were purpura/bleeding from 
different sites in 57 (62.2%), reluctance to feed in 
51(56%), lethargy also in 51 (56%), poor tolerance to 
feeding in 33(36.2%) and altered level of consciousness 
in 24(26.3%)–Figure 1.  
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 Figure 1: Clinical findings in study patients (N = 91) 
Total leucocyte count was measured in all the study 
patients. The mean TLC was 18713/cmm ranging from 
13400 to 30000/cmm. Majority of the patients- 56(61.5%) 
had TLC between 15001 and 20000cmm, 19(20.8%) had 
TLC between 13000 and 15000/cmm whereas 10(10.9%) 
had TLC between 20001 and 25000/cmm and 6 (6.5%) 
were found to have TLC between 25001 and 30000/cmm- 
Table 1. 
 As per our study objective the frequency of raised CRP 
was measured in all the patients. Vast majority of the 
patients- 87(95.6%) were found to have an increased 
CRP level while in only 4(4.4%) patients, CRP was not 
raised- Table 2. 
Table 1. Total Leukocyte Count in the study patients 
(N = 91) 
TLC (cmm) Number (%) 
13000 to 15000 19 (20.9) 
15001 to 20000 56 (61.5) 
20001 to 25000 10 (11) 
25001 to 30000 6 (6.6) 
Table 2: CRP findings in study patients (n = 91) 
C-reactive protein Number (%) 
    Increased 
   Not increased 
87 (95.6) 
04 (4.4) 
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D i s c u s s i o n  
CRP has been fairly extensively studied as a useful 
marker of bacterial sepsis in neonates and children. 11-15 
Other studies which have also reviewed the same.16, 17 
Ammo K et al prospectively studied the utility of CRP and 
ESR as a diagnostic marker for sepsis in neonates, 
evaluating 293 episodes of sepsis in 163 infants.18 
Complete blood counts with differentials, blood cultures, 
CRP and ESR were measured. As expected hematologic 
profile of sepsis episodes were characterized by higher 
white blood cell counts among other indices. In their study 
the CRP and ESR in combination with absolute neutrophil 
count had the highest negative predictive value (93%) for 
ruling out sepsis and 95% sensitivity for diagnosing 
sepsis. They concluded that CRP and ESR are highly 
sensitive markers for neonatal sepsis and recommended 
prospective studies incorporating CRP and ESR into a 
sepsis scoring system. In comparison, our study though 
not confined to neonates, had a number of neonates as 
part of the study population. Though we did not evaluate 
the data of neonates separately but in general we also 
concluded that raised TLC and CRP levels were present 
in the vast majority of patients clinically diagnosed to have 
sepsis. Sidra Younis et al also studied the diagnostic 
accuracy of CRP in neonatal sepsis.12 They enrolled 59 
consecutive patients with risk factors and clinical features 
suggestive of sepsis. CRP and blood cultures were taken 
from all patients. In their study, the sensitivity, specificity, 
positive predictive value and negative predictive value of 
raised CRP were found to be 97.3%, 95.2%, 97.3% and 
95.2% respectively. Blood cultures were positive in 64.4% 
and raised CRP was found in 64.5% cases. They 
concluded that CRP has high sensitivity and specificity for 
establishing the diagnosis of neonatal sepsis which is 
comparable to that of blood culture results. In comparison, 
our study only included patients who were clinically 
diagnosed to have sepsis and CRP was not compared to 
blood cultures and this was a limitation of our study. 
Michal Kyr et al studied the role of the time course of CRP 
levels in association with clinical outcomes in children with 
different septic conditions in an intensive care 
environment.19 They performed a retrospective analysis of 
99 patients with inflammatory response syndrome, sepsis 
or septic shock syndrome. They monitored the CRP level 
for 10 days following the onset of the septic condition and 
determined that there is a significant effect of septic 
condition and diagnosis on the course of CRP levels. In 
patients who did not progress to septic shock, CRP blood 
levels decreased rapidly after reaching peak values in 
contrast to the values in patients with septic shock in 
whom CRP levels decreased slowly. They concluded that 
the more severe the systemic reaction to the insult, the 
higher and the more prolonged the CRP levels. Their 
study population had an average age of 7.6 years with a 
range of 0.1-18.5 years an age range which was much 
higher than in our study (mean age, 2.6 years with a 
range of 0.1-5 years). Moreover, we did not do 
quantitative or serial CRP levels in our study. Both studies 
emphasize the role of CRP in sepsis, however, the study 
by Michal Kyr et al goes a step further in evaluating the 
role of serial measurements of CRP and understanding 
the pattern of change in levels of CRP and relating it to 
sepsis severity. 
Lanziotti et al published an excellent review on the use of 
biomarkers in the screening, diagnosis, prognosis (risk 
stratification), monitoring of therapeutic response and 
rationale use of antibiotics (e.g. determining the adequate 
treatment length) in children with sepsis.20 Their emphasis 
was on evaluating the role of CRP, procalcitonin, 
interleukin 6, 8 and 18 and a few other markers in this 
context. They evaluated five main publications on the use 
of CRP in pediatric infection/sepsis and concluded that 
the use of biomarkers, including CRP, in pediatric sepsis 
cases is promising, although their use should always be 
correlated with clinical evaluation.21-25 They emphasized 
that combined use of multiple biomarkers has a much 
better sensitivity and specificity in the diagnosis and 
prognosis of sepsis compared to the use of a single 
biomarker. In their view biomarkers, such as CRP and 
procalcitonin have shown a key role in clinical practice 
and CRP is especially useful for the evaluation of the 
response to antibiotic treatment when evaluated serially. 
Other advantages of CRP that they enumerated were that 
it is easily available, has low cost, peaks 36-50 hours after 
an inflammatory trigger and is not affected by 
immunosuppression, renal dysfunction or corticosteroid 
use. They also sited limitations of CRP testing in that it 
has variable sensitivity for detecting bacterial infections 
(lower when a single level is measured) and also that it 
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has low accuracy. Thus, they concluded that the dynamic 
and judicious use of CRP combined with clinical criteria 
and/or other biomarkers has great value and should be 
considered in sepsis diagnosis and especially in sepsis 
treatment evaluation where it probably has a better role 
than in the diagnosis. 
Our study certainly had a number of limitations. Firstly, it 
was a descriptive series only looking at the frequency of 
raised CRP levels in children clinically suspected of 
having sepsis. A control group or a validating test like 
blood culture would have helped to measure actual 
accuracy. Selection bias always remains a possibility in 
observational studies with convenient sampling 
procedures. Moreover, we did not do quantitative or serial 
CRP measurements as were done in most of the above-
cited studies. However, our study did carry the 
advantages of being the first study of its kind in our local 
setting, including a number of neonatal and preschool 
children in the study population and using an easily 
available low cost test like CRP and determining whether 
it could be used as an early surrogate marker of infection 
in children clinically suspected of having sepsis. 
C o n c l u s i o n  
In children, up to 5 years of age clinically suspected of 
having sepsis a raised total white cell count along with a 
raised CRP are present in the vast majority and therefore 
these two indicators together may be used as early 
surrogate markers of sepsis in this paediatric age group. 
Better powered studies are needed in our setup to 
validate this conclusion. 
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